Osteoarthritis is one of the most common causes of joint pain and limited mobility. As cartilage wears down, pain, stiffness, and reduced ability to bear weight can significantly impair quality of life.
In addition to exercise therapy, physical therapy, and proven injection therapies, other conservative treatment options are available today. One of these is peptide therapy using injectable collagen peptides.
It takes a biological approach and is designed to support the joint’s natural environment. At ROC, we use peptide therapy as a potential component of an individualized treatment plan for osteoarthritis—always based on a thorough orthopedic examination and tailored to the specific findings.
Peptides are short chains of amino acids and occur naturally in the human body. They perform numerous functions in metabolism and in communication between cells.
Special injectable collagen peptides are available for the treatment of osteoarthritis. These are injected directly into the affected joint.
Collagen is an essential component of joint cartilage. The goal of the treatment is to support the biological conditions within the joint and positively influence cartilage metabolism. Unlike treatments focused solely on pain relief, peptide therapy does not target only the symptoms but takes a biological approach to treatment.
Healthy joint cartilage consists largely of collagen fibers. In osteoarthritis, the structure and composition of this tissue undergo progressive changes.
Experimental and clinical studies suggest that injectable collagen peptides may influence the activity of cartilage cells and support biological processes in the joint. As a result, they could help improve the joint environment.
The scientific evidence is constantly evolving. Initial studies show positive effects on pain and joint function in patients with osteoarthritis. At the same time, further research is needed to conclusively assess the long-term effectiveness of various treatments.
The most common use is the treatment of osteoarthritis in various joints, particularly:
In addition, in select cases, this treatment may also be considered for cartilage damage or early degenerative changes in the joint.
Whether peptide therapy is appropriate depends, among other things, on the extent of the cartilage damage, the symptoms, and the individual treatment goals.
A thorough orthopedic examination is performed before each treatment. Imaging techniques such as X-rays or MRI help assess the condition of the joint and rule out other causes of the symptoms.
The injection is administered on an outpatient basis under sterile conditions directly into the affected joint.
Depending on the product used and the individual situation, a series of several treatments may be advisable. The exact treatment plan is determined on a case-by-case basis.
After treatment, patients can usually resume their daily activities fairly quickly. Strenuous physical activity should be avoided during the first few days.
Peptide therapy can offer various benefits:
The results that can be achieved depend on various factors, such as the severity of osteoarthritis, the overall condition of the joint, and any underlying medical conditions.
Both peptide therapy and hyaluronic acid are forms of conservative injection therapy for osteoarthritis. However, they take different approaches.
Hyaluronic acid is said to improve the joint's lubrication and act as an additional shock absorber. This can help relieve pain and support mobility.
Peptide therapy, on the other hand, takes a biological approach. Injectable collagen peptides are intended to support the joint environment and cartilage metabolism. The goal is to positively influence the natural processes within the joint.
The most appropriate treatment for each individual case depends, among other things, on the severity of osteoarthritis, the symptoms, the affected joint, and the patient’s individual treatment goals. In some cases, a combination of various conservative treatments may also be appropriate.
Research on injectable collagen peptides is advancing rapidly. Several clinical studies report improvements in pain, mobility, and joint function in patients with osteoarthritis.
At the same time, the body of research is still limited. In particular, larger, long-term randomized trials are needed to conclusively evaluate the efficacy of various medications.
For this reason, we do not view peptide therapy as a substitute for established treatment methods, but rather as a potential supplement within a personalized conservative treatment plan.
Osteoarthritis is rarely caused by cartilage alone. Muscles, joint mechanics, metabolism, inflammatory processes, and individual stress factors also influence the course of the disease.
That is why we develop a personalized treatment plan for each patient. Depending on the findings, we combine various conservative and regenerative procedures, such as:
The most appropriate treatment always depends on the cause of your symptoms and your personal treatment goals.